# Pharmacodynamics and Non-Clinical Inferiority of Heparin Sodium (Cristália) Compared With the Product Liquemine (Roche) in Chronic Renal Failure

> **NCT00828776** · PHASE2,PHASE3 · COMPLETED · sponsor: **Azidus Brasil** · enrollment: 62 (actual)

## Conditions studied

- Chronic Renal Failure

## Interventions

- **BIOLOGICAL:** Heparin sodic - Cristália
- **BIOLOGICAL:** heparin - Liquemine (Roche)

## Key facts

- **NCT ID:** NCT00828776
- **Lead sponsor:** Azidus Brasil
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-02
- **Final completion:** 2008-03
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2009-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00828776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00828776, "Pharmacodynamics and Non-Clinical Inferiority of Heparin Sodium (Cristália) Compared With the Product Liquemine (Roche) in Chronic Renal Failure". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00828776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*